EuBiologics Amends UNICEF Cholera Vaccine Supply Contract End Date… No Change in Contract Value, Neutral for Shareholders
EuBiologics filed an amendment on July 16, 2026, extending the end date of its oral cholera vaccine supply contract with UNICEF from September 12, 2026 to December 31, 2026.
The contract amount remains unchanged at KRW 10.1 billion, representing 6.77% of 2025 sales. This change is purely administrative with no financial impact.
UNICEF is a highly credible international relief agency with stable payment terms. No additional capital raising or share dilution occurs.
[AI Summary]This amendment is a procedural change to the contract end date with no material alteration to the contract's value or terms. The event is neutral for shareholder value.
KOSDAQ Filing Information
[Correction Of Description] Conclusion Of Single Sales And Supply Agreement (Voluntary Disclosure)